Steve Freihon/Related-Oxford
New York, New York
Capability: Expertise
AI Engine in Silico Trials: Aortic Graft Stent Demonstrator
August 17, 2022
Animations of a representative unsuccessful (i.e., proximal Type IA endoleak) thoracic stent graft deployment (left) and a representative successful (i.e., no endoleak) thoracic stent graft deployment (right).
Authors
Abstract
The medical device industry recognizes the general motivation for in silico trials. The CORE.AI project at Thornton Tomasetti aims to create an automated workflow for medical device in silico trials. In this work, the goal of the in-silico trial is to assess the efficacy and safety of a generic, representative thoracic stent graft for the treatment of a thoracic aortic aneurysm (TAA).